Cargando…

NovoPen Echo(®) insulin delivery device

The introduction of insulin pen devices has provided easier, well-tolerated, and more convenient treatment regimens for patients with diabetes mellitus. When compared with vial and syringe regimens, insulin pens offer a greater clinical efficacy, improved quality of life, and increased dosing accura...

Descripción completa

Detalles Bibliográficos
Autores principales: Hyllested-Winge, Jacob, Sparre, Thomas, Pedersen, Line Kynemund
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708877/
https://www.ncbi.nlm.nih.gov/pubmed/26793007
http://dx.doi.org/10.2147/MDER.S59229
_version_ 1782409565190488064
author Hyllested-Winge, Jacob
Sparre, Thomas
Pedersen, Line Kynemund
author_facet Hyllested-Winge, Jacob
Sparre, Thomas
Pedersen, Line Kynemund
author_sort Hyllested-Winge, Jacob
collection PubMed
description The introduction of insulin pen devices has provided easier, well-tolerated, and more convenient treatment regimens for patients with diabetes mellitus. When compared with vial and syringe regimens, insulin pens offer a greater clinical efficacy, improved quality of life, and increased dosing accuracy, particularly at low doses. The portable and discreet nature of pen devices reduces the burden on the patient, facilitates adherence, and subsequently contributes to the improvement in glycemic control. NovoPen Echo(®) is one of the latest members of the NovoPen(®) family that has been specifically designed for the pediatric population and is the first to combine half-unit increment (=0.5 U of insulin) dosing with a simple memory function. The half-unit increment dosing amendments and accurate injection of 0.5 U of insulin are particularly beneficial for children (and insulin-sensitive adults/elders), who often require small insulin doses. The memory function can be used to record the time and amount of the last dose, reducing the fear of double dosing or missing a dose. The memory function also provides parents with extra confidence and security that their child is taking insulin at the correct doses and times. NovoPen Echo is a lightweight, durable insulin delivery pen; it is available in two different colors, which may help to distinguish between different types of insulin, providing more confidence for both users and caregivers. Studies have demonstrated a high level of patient satisfaction, with 80% of users preferring NovoPen Echo to other pediatric insulin pens.
format Online
Article
Text
id pubmed-4708877
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-47088772016-01-20 NovoPen Echo(®) insulin delivery device Hyllested-Winge, Jacob Sparre, Thomas Pedersen, Line Kynemund Med Devices (Auckl) Review The introduction of insulin pen devices has provided easier, well-tolerated, and more convenient treatment regimens for patients with diabetes mellitus. When compared with vial and syringe regimens, insulin pens offer a greater clinical efficacy, improved quality of life, and increased dosing accuracy, particularly at low doses. The portable and discreet nature of pen devices reduces the burden on the patient, facilitates adherence, and subsequently contributes to the improvement in glycemic control. NovoPen Echo(®) is one of the latest members of the NovoPen(®) family that has been specifically designed for the pediatric population and is the first to combine half-unit increment (=0.5 U of insulin) dosing with a simple memory function. The half-unit increment dosing amendments and accurate injection of 0.5 U of insulin are particularly beneficial for children (and insulin-sensitive adults/elders), who often require small insulin doses. The memory function can be used to record the time and amount of the last dose, reducing the fear of double dosing or missing a dose. The memory function also provides parents with extra confidence and security that their child is taking insulin at the correct doses and times. NovoPen Echo is a lightweight, durable insulin delivery pen; it is available in two different colors, which may help to distinguish between different types of insulin, providing more confidence for both users and caregivers. Studies have demonstrated a high level of patient satisfaction, with 80% of users preferring NovoPen Echo to other pediatric insulin pens. Dove Medical Press 2016-01-07 /pmc/articles/PMC4708877/ /pubmed/26793007 http://dx.doi.org/10.2147/MDER.S59229 Text en © 2016 Hyllested-Winge et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Review
Hyllested-Winge, Jacob
Sparre, Thomas
Pedersen, Line Kynemund
NovoPen Echo(®) insulin delivery device
title NovoPen Echo(®) insulin delivery device
title_full NovoPen Echo(®) insulin delivery device
title_fullStr NovoPen Echo(®) insulin delivery device
title_full_unstemmed NovoPen Echo(®) insulin delivery device
title_short NovoPen Echo(®) insulin delivery device
title_sort novopen echo(®) insulin delivery device
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708877/
https://www.ncbi.nlm.nih.gov/pubmed/26793007
http://dx.doi.org/10.2147/MDER.S59229
work_keys_str_mv AT hyllestedwingejacob novopenechoinsulindeliverydevice
AT sparrethomas novopenechoinsulindeliverydevice
AT pedersenlinekynemund novopenechoinsulindeliverydevice